3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Neoplasms
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Colonic Neoplasms
1
Cachexia
1
Biliary Tract Neoplasms
1
Anus Neoplasms
1
Interventions
Gemcitabine
685
130-nm albumin-bound paclitaxel
199
Fluorouracil
190
Oxaliplatin
177
Albumin-Bound Paclitaxel
154
Capecitabine
137
Leucovorin
133
Irinotecan
114
Radiotherapy
96
Taxes
85
pembrolizumab
81
Cisplatin
73
Erlotinib Hydrochloride
70
Radiosurgery
69
Nivolumab
56
Drug Therapy
56
Bevacizumab
54
Magnetic Resonance Spectroscopy
51
Cyclophosphamide
50
folfirinox
45
Specimen Handling
43
Docetaxel
42
Cetuximab
40
Biopsy
39
irinotecan sucrosofate
38
S 1 (combination)
36
Pancreaticoduodenectomy
35
Blood Specimen Collection
34
Surgical Procedures, Operative
31
Paclitaxel
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Ibuprofen
×
Gastrointestinal
×
Clear all
NCT04907864
2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2
Unknown
112 enrolled